Catalogue Number
CT271
Description
mAb anti-human TNF-α (B-C7) - 0.5 mg
Price
€ 280.00
Characteristics
clone B-C7
Summary
The monoclonal antibody to human TNF-alpha (clone B-C7) has shown to be suitable for intracellular staining (Birebent B. et al. 1998) and neutralization assays (Hamacher J. et al. 2002 and van Hensbroek M.B. et al. 1996). B-C7 antibody recognizes both natural and recombinant human TNF-alpha and can be used in ELISA (Robinet E. et al. 1997) and immunohistochemistry (Voorzanger N. et al. 1996).
References list
- TCR repertoire and cytokine profiles of cerebrospinal fluid- and peripheral blood-derived T lymphocytes from patients with multiple sclerosis.
- Tumor necrosis factor-alpha and angiostatin are mediators of endothelial cytotoxicity in bronchoalveolar lavages of patients with acute respiratory distress syndrome.
- Erucylphosphocholine-induced apoptosis in glioma cells: involvement of death receptor signalling and caspase activation.
- CD4 monoclonal antibody administration in atopic dermatitis.
- The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria.
- Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors.
- TNF-α produced by SEC2 mutant (SAM-3)-activated human T cells induces apoptosis of HepG2 cells.